Cardinal Health’s Revenue by Segment (2016-2023)

This statistic highlights Cardinal Health’s Revenue by Segment, reported on a quarterly basis and split across Medical and Pharmaceutical segments, reported on a quarterly basis from Q1 2016 onwards.

Cardinal Health’s Revenue by Segment

(All figures are in millions, except percentage)

Cardinal Health’s revenue increased from $39,069 million in Q1 2021 to $43,971 million in Q1 2022, marking a 12.54% growth on a year-on-year basis. It also grew by 3.24% as compared to $42,590 million earned in Q4 2021.

Cardinal Health’s revenue is further bifurcated into the following segments:

Pharmaceutical

• Pharmaceuticals, including branded and generic, specialty pharmaceuticals, and over-the-counter healthcare and consumer items are distributed in the United States through the Pharmaceutical segment.
• This business segment also repackages generic pharmaceuticals and other healthcare products for pharmaceutical manufacturers and healthcare providers; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; and provides pharmacy management services to hospitals, other healthcare providers, and payers.

Cardinal Health’s revenue from the Pharmaceutical segment increased from $35,112 million in Q1 2021 to $36,822 million in Q1 2022, marking an increment of 9.2% on a year-on-year basis. In Q4 2021, the major contribution to the company’s revenue, of 90% was made by the Pharmaceutical segment.

The increase in Pharmaceutical segment profit was mostly attributable to increased volume compared to the prior-year period, which was negatively impacted by COVID-19, and was largely offset by increased expenses linked to information technology infrastructure investments.

Medical

• Cardinal Health’s medical, surgical, and laboratory goods are manufactured, sourced, and distributed in the United States, Canada, Europe, Asia, and other regions by the Medical segment.
• The Medical segment also provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories,. and other healthcare providers. Through the Cardinal Health at-Home Solutions business, this section also delivers medical items to patients’ homes in the U.S.

Cardinal Health’s revenue from the Medical segment showed an increment from $3,957 million in Q1 2021 to $4,149 million in Q1 2022, indicating a 4.85% growth on a year-on-year basis. The medical segment was responsible for contributing 9% to total revenue in Q1 2022.

The rise was principally attributable to the growing emphasis on PPE, greater volumes in the company’s laboratory business, and an increase in the volume of surgical items used in elective surgeries, which was slightly offset by the impact of the Cordis business divestment.

About the Company

Cardinal Foods was formed in 1971 by Robert D. Walter and was originally a food wholesaler. It began wholesaling medications after acquiring the Bailey Drug Company in 1979. In 1983, the firm went public on the NASDAQ stock exchange. Cardinal Health became the third-largest pharmaceutical wholesaler in the United States after changing its name in 1994.

Cardinal Health is a global provider of tailored healthcare services and products for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients at home. It provides pharmaceuticals, and medical products, as well as cost-effective supply chain solutions. For better patient management and integrated care coordination, they also connect with patients, providers, payers, pharmacists, and manufacturers.

Did you like Cardinal Health’s Revenue by Segment statistic?

Access thousands of more such key performance indicator data points, on thousands of US stocks, with Business Quant.

You can get started here.